Investigators: Beth Arrowsmith, Camille Gibson, Christina Anthony, Fiona McDonald, Jan Jones, Jane Jones, Jennifer Gatens, Jennifer Kent, Krist Ewe, Nikki Schultz, Peter Richmond, Tanya Stoney
Project description
In this study we will be assessing the safety and immune response created by the new pneumococcal vaccine (V114) in babies. This includes assessing the immune response of the V114 vaccine when it is given at the same time as other routine childhood vaccines used in Australia, including Rotarix™ and Infanrix™ Hexa.
Partners
- Merck Sharp Dohme